Search Results - "Matsue, Kosei"

Refine Results
  1. 1

    Bone Marrow Necrosis in Acute Monoblastic Leukemia by Terao, Toshiki, Matsue, Kosei

    Published in The New England journal of medicine (18-02-2021)
    “…A 56-year-old man presented with fever and shortness of breath. The white-cell count was 142,000 per microliter, and a diagnosis of acute monoblastic leukemia…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    Antibody response to COVID-19 vaccine in 130 recipients of hematopoietic stem cell transplantation by Tsushima, Takafumi, Terao, Toshiki, Narita, Kentaro, Fukumoto, Ami, Ikeda, Daisuke, Kamura, Yuya, Kuzume, Ayumi, Tabata, Rikako, Miura, Daisuke, Takeuchi, Masami, Matsue, Kosei

    Published in International journal of hematology (01-05-2022)
    “…We evaluated anti-spike protein antibody (anti-S) production in 130 hematopoietic stem cell transplant (HSCT) recipients who received the coronavirus…”
    Get full text
    Journal Article
  12. 12

    Prognostic relevance of tumor-infiltrating CD4 + cells and total metabolic tumor volume-based risk stratification in diffuse large B-cell lymphoma by Ikeda, Daisuke, Oura, Mitsuaki, Uehara, Atsushi, Tabata, Rikako, Narita, Kentaro, Takeuchi, Masami, Machida, Youichi, Matsue, Kosei

    Published in Haematologica (Roma) (01-09-2024)
    “…In order to elucidate the relationship between pretreatment radiomic parameters and the proportions of various tumor-infiltrating (TI) cells, we…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Comparison of minimal residual disease detection in multiple myeloma between the DuraClone and EuroFlow methods by Yoroidaka, Takeshi, Narita, Kentaro, Takamatsu, Hiroyuki, Fujisawa, Momoko, Nakao, Shinji, Matsue, Kosei

    Published in Scientific reports (27-05-2021)
    “…In this study, the minimal residual disease (MRD) levels in patients with multiple myeloma (MM) were assessed by comparing the new 8-color single-tube…”
    Get full text
    Journal Article
  16. 16

    Fatal thrombotic microangiopathy with rhabdomyolysis as an initial symptom after the first dose of mRNA–1273 vaccine: A case report by Kamura, Yuya, Terao, Toshiki, Akao, Satoshi, Kono, Yumi, Honma, Koichi, Matsue, Kosei

    “…•The patient developed leg pain and livedo reticularis after mRNA-1273 vaccination.•His blood creatine kinase level was markedly elevated and MRI showed…”
    Get full text
    Journal Article
  17. 17

    Total diffusion volume in MRI vs. total lesion glycolysis in PET/CT for tumor volume evaluation of multiple myeloma by Terao, Toshiki, Machida, Youichi, Narita, Kentaro, Kuzume, Ayumi, Tabata, Rikako, Tsushima, Takafumi, Miura, Daisuke, Takeuchi, Masami, Tateishi, Ukihide, Matsue, Kosei

    Published in European radiology (01-08-2021)
    “…Objective This study compared the tumor burden and prognostic impact of total diffusion volume (tDV) and total lesion glycolysis (TLG) in the same patients…”
    Get full text
    Journal Article
  18. 18

    Multiple myeloma with t(11;14)‐associated immature phenotype has lower CD38 expression and higher BCL2 dependence by Kitadate, Akihiro, Terao, Toshiki, Narita, Kentaro, Ikeda, Sho, Takahashi, Yuto, Tsushima, Takafumi, Miura, Daisuke, Takeuchi, Masami, Takahashi, Naoto, Matsue, Kosei

    Published in Cancer science (01-09-2021)
    “…CD38 expression on myeloma cells is a critical factor affecting the early response to the anti‐CD38 antibody daratumumab. However, factors affecting CD38…”
    Get full text
    Journal Article
  19. 19

    Antibody response to COVID-19 vaccination in patients with lymphoma by Narita, Kentaro, Nakaji, So, Tabata, Rikako, Terao, Toshiki, Kuzume, Ayumi, Tsushima, Takafumi, Ikeda, Daisuke, Fukumoto, Ami, Miura, Daisuke, Takeuchi, Masami, Doi, Masahiro, Umezawa, Yuka, Otsuka, Yoshihito, Takamatsu, Hiroyuki, Matsue, Kosei

    Published in International journal of hematology (01-05-2022)
    “…Patients with lymphoma are at increased risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); therefore, evaluation of SARS-CoV-2 vaccination…”
    Get full text
    Journal Article
  20. 20